As 2018 takes shape, the time has come for an update on my Starter Portfolios. First published in the March 2017 issue of The Daily Paycheck, these three portfolios offer an easy template for investors from all walks of life, on any budget. And today, I’m letting all StreetAuthority readers in on the action with a preview of each portfolio’s holdings. (To get full access to these portfolios –and the rest of my Daily Paycheck picks — follow this link.) OK, so here’s how this works… #-ad_banner-#I’m going to show you three portfolios — each of which could easily be… Read More

As 2018 takes shape, the time has come for an update on my Starter Portfolios. First published in the March 2017 issue of The Daily Paycheck, these three portfolios offer an easy template for investors from all walks of life, on any budget. And today, I’m letting all StreetAuthority readers in on the action with a preview of each portfolio’s holdings. (To get full access to these portfolios –and the rest of my Daily Paycheck picks — follow this link.) OK, so here’s how this works… #-ad_banner-#I’m going to show you three portfolios — each of which could easily be started with as little as $10,000 or even less. They are designed to address a variety of stages of an investor’s saving/investing/spending cycles. They could also easily be adapted to fit a variety of risk tolerances, timelines, and investment goals. Also, the income from these portfolios can all be reinvested — a key element of my Daily Paycheck strategy. Bottom line, think of these as a “first step” guide for starting a diversified portfolio — as a base to be built upon, with new investments, new funds, stocks and bonds to be added along the way. Aggressive Portfolio For… Read More

Remember the good ol’ days of 2017? The market was climbing. Volatility was falling. And investors could do no wrong by putting their money into whatever was dominating the headlines at the moment. —Sponsored Link— 3 Hot Marijuana Stocks To Buy Before July 1 Since California dispensaries started to legally sell recreational marijuana on January 1, companies in the cannabis industry have increased by nearly $2 billion in value. And now Canada is set to legalize recreational marijuana by July 2018. Savvy investors are already grabbing positions in these three stocks… Read More

Remember the good ol’ days of 2017? The market was climbing. Volatility was falling. And investors could do no wrong by putting their money into whatever was dominating the headlines at the moment. —Sponsored Link— 3 Hot Marijuana Stocks To Buy Before July 1 Since California dispensaries started to legally sell recreational marijuana on January 1, companies in the cannabis industry have increased by nearly $2 billion in value. And now Canada is set to legalize recreational marijuana by July 2018. Savvy investors are already grabbing positions in these three stocks that are set to soar once the announcement is made. And, of course, the FAANG stocks were at their height. This catchy name stands for Facebook (Nasdaq: FB), Amazon (Nasdaq: AMZN), Apple (Nasdaq: AAPL), Netflix (Nasdaq: NFLX) and Google (Nasdaq: GOOGL). This group was supposed to represent the most popular technology stocks of this market. #-ad_banner-#Whether it was a self-fulfilling prophecy or simply really strong momentum (or both), the year-end Bloomberg analysis showed that the FAANGs (or a slight modification on that acronym) were instrumental in 2017’s record-setting market performance. In fact, taken together, Facebook, Apple, Amazon, Microsoft (Nasdaq: MSFT)… Read More

There are few words in the English language that are hated more than “cancer.” And as far as public health dangers go, it’s one of the biggest enemies anyone could imagine.  According to the World Health Organization (WHO), cancer is one of the leading causes of mortality in the world — it’s responsible for nearly 1 in 6 deaths. And the danger isn’t going away anytime soon — the WHO estimates that the number of cases in total will grow by 70% over the next two decades. The sheer size of the threat also means the amount of brainpower and… Read More

There are few words in the English language that are hated more than “cancer.” And as far as public health dangers go, it’s one of the biggest enemies anyone could imagine.  According to the World Health Organization (WHO), cancer is one of the leading causes of mortality in the world — it’s responsible for nearly 1 in 6 deaths. And the danger isn’t going away anytime soon — the WHO estimates that the number of cases in total will grow by 70% over the next two decades. The sheer size of the threat also means the amount of brainpower and money the problem attracts will also be huge. Big pharma and smaller biotech companies alike have made it their business to find a cure — or at least the best treatment when the cure has remained out of reach. This area of medicine has seen significant breakthroughs over the past several decades, and more are on the horizon.  The Future Of Cancer-Fighting Medicines One of the breakthroughs that have changed the approach to cancer treatment — and can be credited with saving many lives — is immunotherapy.  #-ad_banner-#With this approach, the patient’s own immune system is utilized to attack… Read More